selected scholarly activity
-
conferences
- MICROBIOTA FROM PATIENTS WITH CROHN'S DISEASE INDUCES BEHAVIOURAL CHANGES IN MICROBIOTA-HUMANIZED MICE. Gastroenterology. S87-S87. 2023
- ARYL HYDROCARBON RECEPTOR LIGAND PRODUCTION BY THE GUT MICROBIOTA IN CELIAC DISEASE. Gastroenterology. S217-S217. 2020
-
journal articles
- Gluten-Dependent Activation of CD4+ T Cells by MHC Class II–Expressing Epithelium. Gastroenterology. 167:1113-1128. 2024
- Oral tryptophan activates duodenal aryl hydrocarbon receptor in healthy subjects: a crossover randomized controlled trial. American Journal of Physiology - Gastrointestinal and Liver Physiology. 326:G687-G696. 2024
- 16 INFLAMMATORY BOWEL DISEASE (IBD)-ASSOCIATED MICROBIOTA ALTER VISCERAL SENSITIVITY AND BEHAVIOUR IN MICROBIOTAHUMANIZED MICE.. Gastroenterology. 166:S-5. 2024
- 794 GLUTEN DEPENDENT ACTIVATION OF CD4+ T CELLS BY MHC CLASS II EXPRESSING INTESTINAL EPITHELIAL CELLS. Gastroenterology. 166:S-196. 2024
- Tu1655 DISCLOSURE OF DIET TRIGGERS DOES NOT ALTER DIETARY CHOICES IN PATIENTS WITH IRRITABLE BOWEL SYNDROME (IBS) AND SELFREPORTED GLUTEN SENSITIVITY. Gastroenterology. 166:S-1367. 2024
- Tu1670 BACTERIAL LYSOPHOSPHATIDYLCHOLINE (LPC) AND LYSOPHOSPHATIDIC ACID (LPA) INDUCE VISCERAL HYPERSENSITIVITY AND LOW-GRADE COLONIC INFLAMMATION IN IRRITABLE BOWEL SYNDROME (IBS). Gastroenterology. 166:S-1373. 2024
- A13 MICROBIOTA FROM PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD) INDUCE ALTERED BEHAVIOUR AND VISCERAL HYPERSENSITIVITY IN MICROBIOTA-HUMANIZED MICE. Journal of the Canadian Association of Gastroenterology. 7:7-7. 2024
- A176 RESTORATION OF IMPAIRED MICROBIOTA-MEDIATED ARYL HYDROCARBON RECEPTOR SIGNALING IN PATIENTS WITH CELIAC DISEASE BY ORAL TRYPTOPHAN SUPPLEMENTATION: AN EXPLORATORY STUDY. Journal of the Canadian Association of Gastroenterology. 7:138-139. 2024
- A22 INVESTIGATING THE EFFECTS OF DIET TRIGGER DISCLOSURE ON BEHAVIOUR IN IRRITABLE BOWEL SYNDROME (IBS) PATIENTS WITH PERCEIVED GLUTEN SENSITIVITY. Journal of the Canadian Association of Gastroenterology. 7:12-13. 2024
- A36 EFFECT OF FIBRE SUPPLEMENTATION IN CELIAC DISEASE: IMPLICATIONS FOR MUCOSAL HEALING. Journal of the Canadian Association of Gastroenterology. 7:20-21. 2024
- A6 LYSOPHOSPHATIDYLCHOLINE (LPC) AND LYSOPHOSPHATIDIC ACID (LPA) INDUCE VISCERAL HYPERSENSITIVITY IN IRRITABLE BOWEL SYNDROME (IBS). Journal of the Canadian Association of Gastroenterology. 7:3-4. 2024
- Crohn’s disease proteolytic microbiota enhances inflammation through PAR2 pathway in gnotobiotic mice. Gut Microbes. 15:2205425. 2023
- 458 MICROBIOTA FROM PATIENTS WITH CROHN'S DISEASE INDUCES BEHAVIOURAL CHANGES IN MICROBIOTA-HUMANIZED MICE. Gastroenterology. 164:S-87. 2023
- 683 INVESTIGATING MECHANISMS THAT DRIVE SYMPTOMS IN PATIENTS WITH IRRITABLE BOWEL SYNDROME AND PERCEIVED GLUTEN SENSITIVITY. Gastroenterology. 164:S-136. 2023
- INVESTIGATING MECHANISMS THAT DRIVE SYMPTOMS IN PATIENTS WITH IRRITABLE BOWEL SYNDROME AND PERCEIVED GLUTEN SENSITIVITY. Gastroenterology. 164:S136-S136. 2023
- MICROBIAL PHOSPHOLIPIDS AS TRIGGERS OF VISCERAL HYPERALGESIA IN IRRITABLE BOWEL SYNDROME. Gastroenterology. 164:S1075-S1075. 2023
- Mo1814 PROTEOLYTIC CROHN'S DISEASE MICROBIOTA ENHANCES INFLAMMATION THROUGH PROTEASE-ACTIVATED RECEPTOR 2 PATHWAY. Gastroenterology. 164:S-921. 2023
- PROTEOLYTIC CROHN'S DISEASE MICROBIOTA ENHANCES INFLAMMATION THROUGH PROTEASE-ACTIVATED RECEPTOR 2 PATHWAY. Gastroenterology. 164:S921-S921. 2023
- Tu1654 MICROBIAL PHOSPHOLIPIDS AS TRIGGERS OF VISCERAL HYPERALGESIA IN IRRITABLE BOWEL SYNDROME. Gastroenterology. 164:S-1075. 2023
- A19 INVESTIGATING MECHANISMS THAT DRIVE SYMPTOMS IN IRRITABLE BOWEL SYNDROME PATIENTS WITH PERCEIVED GLUTEN SENSITIVITY. Journal of the Canadian Association of Gastroenterology. 6:10-11. 2023
- A3 CROHN’S DISEASE PROTEOLYTIC MICROBIOTA ENHANCES INFLAMMATION THROUGH PAR2 PATHWAY IN GNOTOBIOTIC MICE. Journal of the Canadian Association of Gastroenterology. 6:2-2. 2023
- A53 FECAL BIOACTIVE PHOSPHOLIPIDS AS TRIGGERS OF INTESTINAL HYPERSENSITIVITY IN IRRITABLE BOWEL SYNDROME. Journal of the Canadian Association of Gastroenterology. 6:29-30. 2023
- Biogeographic Variation and Functional Pathways of the Gut Microbiota in Celiac Disease. Gastroenterology. 163:1351-1363.e15. 2022
- A248 THE ROLE OF DIETARY TRYPTOPHAN IN INDOLE AND KYNURENINE PRODUCTION AND IMMUNE MODULATION IN HEALTHY INDIVIDUALS. Journal of the Canadian Association of Gastroenterology. 5:141-142. 2022
- A34 GLUTEN-FREE DIET IMPROVES DYSPEPTIC SYMPTOMS IN PATIENTS WITH TYPE 1 DIABETES IN WHOM CELIAC DISEASE WAS EXCLUDED. Journal of the Canadian Association of Gastroenterology. 5:40-41. 2022
- A46 BIOGEOGRAPHIC VARIATION AND FUNCTIONAL PATHWAYS OF THE GUT MICROBIOTA IN CELIAC DISEASE. Journal of the Canadian Association of Gastroenterology. 5:53-54. 2022
- Probióticos en enfermedad celíaca: ¿estamos listos para su aplicación en la práctica clínica?. Acta Gastroenterologica Latinoamericana. 51:394-402. 2021
- Novel Fecal Biomarkers That Precede Clinical Diagnosis of Ulcerative Colitis. Gastroenterology. 160:1532-1545. 2021
- A29 NOVEL FECAL BIOMARKERS THAT PRECEDE CLINICAL DIAGNOSIS OF ULCERATIVE COLITIS. Journal of the Canadian Association of Gastroenterology. 4:268-269. 2021
- A8 DIETARY TRYPTOPHAN MODULATES KYNURENINE AND INDOLE PRODUCTION IN HEALTHY INDIVIDUALS. Journal of the Canadian Association of Gastroenterology. 4:9-10. 2021
- Aryl hydrocarbon receptor ligand production by the gut microbiota is decreased in celiac disease leading to intestinal inflammation. Science Translational Medicine. 12:eaba0624. 2020
- 1123 ARYL HYDROCARBON RECEPTOR LIGAND PRODUCTION BY THE GUT MICROBIOTA IN CELIAC DISEASE. Gastroenterology. 158:S-217. 2020
- A193 GLUTEN-FREE DIET IMPROVES DYSPEPSIA-LIKE SYMPTOMS IN A PILOT STUDY OF PATIENTS WITH TYPE 1 DIABETES MELLITUS. Journal of the Canadian Association of Gastroenterology. 3:64-65. 2020
- A194 PRESENCE OF CELIAC DISEASE IN PATIENTS WITH BARRETT’S ESOPHAGUS IS ASSOCIATED WITH FASTER DEVELOPMENT OF DYSPLASIA AND HIGHER RATES OF ESOPHAGEAL ADENOCARCINOMA. Journal of the Canadian Association of Gastroenterology. 3:65-66. 2020